FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387408919> ?p ?o ?g. }

• W4387408919 endingPage "105048" @default.
• W4387408919 startingPage "105048" @default.
• W4387408919 abstract "Prostate cancers are among the common malignancies in men. Despite the availability of various treatment options, including chemotherapy, radiotherapy, and surgery, the prognosis for advanced prostate tumors remains poor. One of the major challenges in the therapy of prostate cancer is its resistance to conventional therapies. Therefore, there is a requirement to design new therapeutic approaches to enhance the efficacy of anticancer drugs and radiotherapy. In recent years, there has been growing interest in boosting anticancer immunity in various malignancies such as prostate cancer. This approach aims to target several immune interactions in the tumor microenvironment (TME) to enrich the immune system's capacity to identify and eradicate malignant cells. Therefore, understanding these interactions is essential for developing effective immunotherapeutic strategies for prostate cancer. Numerous approaches have been suggested to boost anticancer immunity in prostate cancer, consisting of immune checkpoint inhibitors (ICIs), cancer vaccines, adoptive cell therapy, cytokine-based therapies, adjuvant therapy, nanoparticles, and also targeting some other specific molecules. In the present paper, we will discuss the various approaches for boosting anticancer immunity in prostate cancer and likely therapeutic targets for reducing prostate cancer resistance to anticancer drugs and radiotherapy. We will also emphasize the limitations and forthcoming directions for developing effective immunotherapeutic strategies for prostate cancer." @default.
• W4387408919 created "2023-10-07" @default.
• W4387408919 creator A5031448070 @default.
• W4387408919 creator A5083206728 @default.
• W4387408919 date "2023-11-01" @default.
• W4387408919 modified "2023-10-12" @default.
• W4387408919 title "Approaches for boosting antitumor immunity in prostate cancer therapy: A comprehensive review on drugs, products, and nanoparticles" @default.
• W4387408919 cites W1468841000 @default.
• W4387408919 cites W1480342889 @default.
• W4387408919 cites W1481809543 @default.
• W4387408919 cites W1511609605 @default.
• W4387408919 cites W1529167990 @default.
• W4387408919 cites W1544341564 @default.
• W4387408919 cites W1585970484 @default.
• W4387408919 cites W1684168371 @default.
• W4387408919 cites W1779771004 @default.
• W4387408919 cites W1902176173 @default.
• W4387408919 cites W1952270399 @default.
• W4387408919 cites W1971438869 @default.
• W4387408919 cites W1988943017 @default.
• W4387408919 cites W1998934929 @default.
• W4387408919 cites W2007948290 @default.
• W4387408919 cites W2020293242 @default.
• W4387408919 cites W2021938059 @default.
• W4387408919 cites W2026890342 @default.
• W4387408919 cites W2030679572 @default.
• W4387408919 cites W2042969009 @default.
• W4387408919 cites W2047936140 @default.
• W4387408919 cites W2053136658 @default.
• W4387408919 cites W2054463613 @default.
• W4387408919 cites W2061662618 @default.
• W4387408919 cites W2064164513 @default.
• W4387408919 cites W2067508471 @default.
• W4387408919 cites W2073274327 @default.
• W4387408919 cites W2073447777 @default.
• W4387408919 cites W2074546881 @default.
• W4387408919 cites W2075137329 @default.
• W4387408919 cites W2078937040 @default.
• W4387408919 cites W2084991494 @default.
• W4387408919 cites W2085462535 @default.
• W4387408919 cites W2086846496 @default.
• W4387408919 cites W2089573422 @default.
• W4387408919 cites W2093400957 @default.
• W4387408919 cites W2104922784 @default.
• W4387408919 cites W2105949723 @default.
• W4387408919 cites W2106213736 @default.
• W4387408919 cites W2116746706 @default.
• W4387408919 cites W2126882378 @default.
• W4387408919 cites W2128856207 @default.
• W4387408919 cites W2135844841 @default.
• W4387408919 cites W2149570955 @default.
• W4387408919 cites W2158219426 @default.
• W4387408919 cites W2161665929 @default.
• W4387408919 cites W2162714199 @default.
• W4387408919 cites W2162991161 @default.
• W4387408919 cites W2169258216 @default.
• W4387408919 cites W2176023620 @default.
• W4387408919 cites W2196240536 @default.
• W4387408919 cites W2206971126 @default.
• W4387408919 cites W2209106857 @default.
• W4387408919 cites W2224032420 @default.
• W4387408919 cites W2256034989 @default.
• W4387408919 cites W2266683146 @default.
• W4387408919 cites W2314057593 @default.
• W4387408919 cites W2340809809 @default.
• W4387408919 cites W2395062256 @default.
• W4387408919 cites W2409462535 @default.
• W4387408919 cites W2469380297 @default.
• W4387408919 cites W2515482312 @default.
• W4387408919 cites W2534828940 @default.
• W4387408919 cites W2544852806 @default.
• W4387408919 cites W2548037115 @default.
• W4387408919 cites W2580617289 @default.
• W4387408919 cites W2580657336 @default.
• W4387408919 cites W2587055344 @default.
• W4387408919 cites W2587816384 @default.
• W4387408919 cites W2593111137 @default.
• W4387408919 cites W2593675800 @default.
• W4387408919 cites W2605722715 @default.
• W4387408919 cites W2605999908 @default.
• W4387408919 cites W2617763968 @default.
• W4387408919 cites W2623441466 @default.
• W4387408919 cites W2742471933 @default.
• W4387408919 cites W2755575514 @default.
• W4387408919 cites W2767512341 @default.
• W4387408919 cites W2768486235 @default.
• W4387408919 cites W2772146395 @default.
• W4387408919 cites W2780310856 @default.
• W4387408919 cites W2782676239 @default.
• W4387408919 cites W2789342623 @default.
• W4387408919 cites W2790751214 @default.
• W4387408919 cites W2793411924 @default.
• W4387408919 cites W2794314089 @default.
• W4387408919 cites W2801625416 @default.
• W4387408919 cites W2802095881 @default.
• W4387408919 cites W2804963311 @default.
• W4387408919 cites W2806710293 @default.
• W4387408919 cites W2883285168 @default.

• next